M&A Deal Summary

JLL Partners, Ampersand Capital Partners and Water Street Healthcare Partners Acquire BioClinica

On March 13, 2013, private equity firm JLL Partners, growth capital firm Ampersand Capital Partners and private equity firm Water Street Healthcare Partners acquired life science company BioClinica for 123M USD

Acquisition Highlights
  • This is JLL Partners’ 2nd, Ampersand Capital Partners’ 11th and Water Street Healthcare Partners’ 5th transaction in the Life Science sector.
  • This is JLL Partners’ 8th, Ampersand Capital Partners’ 2nd and Water Street Healthcare Partners’ 4th largest (disclosed) transaction.
  • This is JLL Partners’ 19th, Ampersand Capital Partners’ 31st and Water Street Healthcare Partners’ 22nd transaction in the United States.
  • This is JLL Partners’ 1st, Ampersand Capital Partners’ 4th and Water Street Healthcare Partners’ 2nd transaction in New Jersey.
Investment Fate
  • BioClinica was sold to a consortium of financial buyers in 2016.
  • BioClinica merged with another company in 2020.

M&A Deal Summary
Date 2013-03-13
Target BioClinica
Sector Life Science
Buyer(s) JLL Partners
Ampersand Capital Partners
Water Street Healthcare Partners
Deal Type Going Private
Deal Value 123M USD
Advisor(s) Morgan Lewis (Legal)

Target

BioClinica

Princeton, New Jersey, United States
Bioclinica is an integrated clinical life science solutions provider, delivering powerful insight into clinical trial development, assuring greater client success in bringing medical therapies to market, for people around the world. Through deep medical, scientific, and technology expertise, the company provides medical imaging and cardiac safety services; clinical adjudication; randomization and trial supply management and optimization; electronic and eSource data capture; site and patient payments; clinical trial management software; and drug safety solutions. Bioclinica’s global team of life science experts serves more than 500 pharmaceutical, biotechnology, and device organizations including the top 20 biopharmaceutical companies and leading CROs through offices in North America, Europe, and Asia. Bioclinica was formed in 1990 and is based in Princeton, New Jersey.

Search 201,697 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 3

Buyer

JLL Partners

New York, New York, United States

Investor Investor Investor Investor

Category Private Equity Firm
Founded 1988
PE ASSETS 5.8B USD
Size Mega
Type Sector Agnostic
DESCRIPTION

JLL Partners, Inc. is a private equity investment firm that invests alongside management in middle-market companies. JLL prefers control investments in sectors such as healthcare services, medical products, food and consumer products, chemicals, broadcasting, transportation, automotive, industrial manufacturing, and distribution. In addition to traditional buyout transaction, JLL also seeks distressed/turnaround situations. JLL Partners was formed in 1988 and is based in New York City.

DEAL STATS #
Overall 20 of 40
Sector (Life Science) 2 of 7
Type (Going Private) 3 of 4
State (New Jersey) 1 of 1
Country (United States) 19 of 38
Year (2013) 1 of 3
Size (of disclosed) 8 of 9
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2012-02-09 American Dental Partners

Wakefield, Massachusetts, United States

American Dental Partners is a dental practice management company that provides business services to medically-oriented, multi-specialty dental groups, with over 270 facilities across more than 20 states. ADPI was formed in 1995 and is based in Wakefield, Massachusetts.

Buy $392M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2013-04-08 CCBR-SYNARC

Newark, California, United States

CCBR-SYNARC, Inc. is a medical image-analysis, subject-recruitment, and biochemical marker services enable life-science industry clients to execute clinical trials accurately while decreasing the time, uncertainty, and cost of product development.

Buy -
Buyer

Ampersand Capital Partners

Wellesley, Massachusetts, United States

Investor Investor Investor Investor Investor

Category Growth Capital Firm
Founded 1988
PE ASSETS 3.0B USD
Size Large
Type Sector Focused
DESCRIPTION

Ampersand Capital Partners is a middle-market private equity group that concentrates on growth equity investment opportunities in the healthcare sector. The Firm looks to invest $10 to $100 million in businesses with $10 to $100 million of revenue. Specific areas of interests within healthcare include lab products, specialty diagnostic equipment, pharmaceutical outsourcing, and specialty pharma. Ampersand generally prefers to be the first and sole institutional investor. Ampersand was formed in 1988 and is based in Wellesley, Massachusetts.

DEAL STATS #
Overall 31 of 84
Sector (Life Science) 11 of 43
Type (Going Private) 1 of 2
State (New Jersey) 4 of 7
Country (United States) 31 of 69
Year (2013) 1 of 1
Size (of disclosed) 2 of 4
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2012-11-13 Willow Laboratories

Lynn, Massachusetts, United States

Willow is a clinical and forensic toxicology laboratories providing urine, hair and saliva testing services to a wide range of healthcare providers including treatment centers, physician practices and other laboratories.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2013-03-15 CoreLab Partners

Princeton, New Jersey, United States

CoreLab Partners, Inc. is a provider of linical trials, medical image assessment, and cardiac safety solutions.

Sell -
Buyer

Water Street Healthcare Partners

Chicago, Illinois, United States

Investor Investor Investor Investor Investor

Category Private Equity Firm
Founded 2005
PE ASSETS 6.0B USD
Size Mega
Type Sector Focused
DESCRIPTION

Water Street is a specialist private equity firm that targets investments in healthcare companies. Specific areas of interest within healthcare include diagnostic devices, medical products, pharmaceutical services, specialty distribution, specialty pharmaceuticals, and specialty services. Water Street targets non-core units of larger corporations and private middle-market companies. Transactions are typically valued between $50 and $500 million. Water Street does not invest in biotechnology, traditional healthcare facilities (hospitals, nursing homes) or early-stage companies without positive cash flow. Water Street was formed in 2005 and is based in Chicago, Illinois.

DEAL STATS #
Overall 22 of 50
Sector (Life Science) 5 of 12
Type (Going Private) 1 of 2
State (New Jersey) 2 of 5
Country (United States) 22 of 47
Year (2013) 2 of 5
Size (of disclosed) 4 of 7
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2013-01-01 Capstone Development Solutions

Rosemont, Illinois, United States

Capstone Development Solutions partners with the world’s premier healthcare companies to support their goal of bringing more new products to market, quickly and efficiently. The company leads development, manages regulatory services and achieves timely approval of pharmaceutical and medical device products on its clients' behalf. Capstone Development Solutions was founded in 2013 and is based in Rosemont, Illinois.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2013-04-08 CCBR-SYNARC

Newark, California, United States

CCBR-SYNARC, Inc. is a medical image-analysis, subject-recruitment, and biochemical marker services enable life-science industry clients to execute clinical trials accurately while decreasing the time, uncertainty, and cost of product development.

Buy -
Mergr

Product

Company

Legal